RÉSUMÉ
Anaemia is amongst the major complications of malaria, a major public health problem in the Amazon Region in Latin America. We examined the haemoglobin (Hb) concentrations of malaria-infected patients and compared it to that of malaria-negative febrile patients and afebrile controls. The haematological parameters of febrile patients who had a thick-blood-smear performed at an infectious diseases reference centre of the Brazilian Amazon between December 2009-January 2012 were retrieved together with clinical data. An afebrile community control group was composed from a survey performed in a malaria-endemic area. Hb concentrations and anaemia prevalence were analysed according to clinical-epidemiological status and demographic characteristics. In total, 7,831 observations were included. Patients with Plasmodium falciparum infection had lower mean Hb concentrations (10.5 g/dL) followed by P. vivax-infected individuals (12.4 g/dL), community controls (12.8 g/dL) and malaria-negative febrile patients (13.1 g/dL) (p < 0.001). Age, gender and clinical-epidemiological status were strong independent predictors for both outcomes. Amongst malaria-infected individuals, women in the reproductive age had considerably lower Hb concentrations. In this moderate transmission intensity setting, both vivax and falciparum malaria are associated with reduced Hb concentrations and risk of anaemia throughout a wide age range.
Sujet(s)
Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Nouveau-né , Mâle , Adulte d'âge moyen , Anémie/sang , Hémoglobine A/analyse , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium vivax/sang , Facteurs âges , Anémie/épidémiologie , Anémie/parasitologie , Brésil/épidémiologie , Études cas-témoins , Paludisme à Plasmodium falciparum/complications , Paludisme à Plasmodium falciparum/épidémiologie , Paludisme à Plasmodium vivax/complications , Paludisme à Plasmodium vivax/épidémiologie , Prévalence , Facteurs sexuelsSujet(s)
Animaux , Humains , Antipaludiques/usage thérapeutique , Maladies endémiques , Paludisme à Plasmodium vivax/traitement médicamenteux , Plasmodium vivax/effets des médicaments et des substances chimiques , Brésil/épidémiologie , Essais cliniques comme sujet , Résistance aux substances , Paludisme à Plasmodium vivax/épidémiologie , Paludisme à Plasmodium vivax/parasitologieRÉSUMÉ
Estamos relatando pela primeira vez um paciente com malária por Plasmodium vivax que mostrou resistência R2 à cloroquina e resistência R3 à mefloquina na Amazônia brasileira, de acordo com os critérios clínicos da OMS para resistência da malária. A falha foi observada com cloroquina oral, näo supervisionada, cloroquina oral administrada sob rigorosa supervisäo e com mefloquina no mesmo esquema. A paciente curou com o artesunato oral